Executive Summary
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. More Details
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential with adequate balance sheet.
Share Price & News
How has H&R GmbH KGaA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2HRA is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 2HRA's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
5.4%
2HRA
-3.6%
DE Chemicals
-1.4%
DE Market
1 Year Return
41.1%
2HRA
28.5%
DE Chemicals
27.0%
DE Market
Return vs Industry: 2HRA exceeded the German Chemicals industry which returned 31.5% over the past year.
Return vs Market: 2HRA exceeded the German Market which returned 29.2% over the past year.
Shareholder returns
| 2HRA | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.4% | -3.6% | -1.4% |
| 30 Day | 13.8% | -3.0% | 2.3% |
| 90 Day | 38.8% | -2.6% | 4.8% |
| 1 Year | 41.1%41.1% | 33.8%28.5% | 31.4%27.0% |
| 3 Year | -30.6%-30.6% | -3.5%-14.5% | 27.9%17.4% |
| 5 Year | -29.1%-31.6% | 32.6%10.6% | 64.7%42.1% |
Long-Term Price Volatility Vs. Market
How volatile is H&R GmbH KGaA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire Confidence1 month ago | Simply Wall St
H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value Estimate2 months ago | Simply Wall St
H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?Valuation
Is H&R GmbH KGaA undervalued compared to its fair value and its price relative to the market?
41.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2HRA (€7.76) is trading below our estimate of fair value (€13.36)
Significantly Below Fair Value: 2HRA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2HRA is poor value based on its PE Ratio (98.8x) compared to the German Chemicals industry average (24.3x).
PE vs Market: 2HRA is poor value based on its PE Ratio (98.8x) compared to the German market (26.7x).
Price to Earnings Growth Ratio
PEG Ratio: 2HRA is poor value based on its PEG Ratio (2.5x)
Price to Book Ratio
PB vs Industry: 2HRA is good value based on its PB Ratio (0.9x) compared to the DE Chemicals industry average (2.2x).
Future Growth
How is H&R GmbH KGaA forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
40.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2HRA's forecast earnings growth (40.2% per year) is above the savings rate (0.01%).
Earnings vs Market: 2HRA's earnings (40.2% per year) are forecast to grow faster than the German market (14.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2HRA's revenue (8.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2HRA's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2HRA's Return on Equity is forecast to be high in 3 years time
Past Performance
How has H&R GmbH KGaA performed over the past 5 years?
-50.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2HRA has a large one-off loss of €1.4M impacting its March 31 2021 financial results.
Growing Profit Margin: 2HRA became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 2HRA's earnings have declined by 50.8% per year over the past 5 years.
Accelerating Growth: 2HRA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2HRA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (14.9%).
Return on Equity
High ROE: 2HRA's Return on Equity (1.2%) is considered low.
Financial Health
How is H&R GmbH KGaA's financial position?
Financial Position Analysis
Short Term Liabilities: 2HRA's short term assets (€340.2M) exceed its short term liabilities (€222.4M).
Long Term Liabilities: 2HRA's short term assets (€340.2M) exceed its long term liabilities (€228.9M).
Debt to Equity History and Analysis
Debt Level: 2HRA's debt to equity ratio (44%) is considered high.
Reducing Debt: 2HRA's debt to equity ratio has reduced from 47.9% to 44% over the past 5 years.
Debt Coverage: 2HRA's debt is well covered by operating cash flow (33.4%).
Interest Coverage: 2HRA's interest payments on its debt are not well covered by EBIT (1.9x coverage).
Balance Sheet
Dividend
What is H&R GmbH KGaA current dividend yield, its reliability and sustainability?
0.77%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2HRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2HRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2HRA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2HRA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2HRA is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2HRA's dividend in 3 years as they are not forecast to pay a notable one for the German market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
9.1yrs
Average board tenure
CEO
Niels Hansen (55 yo)
9.42yrs
Tenure
€706,245
Compensation
Mr. Niels H. Hansen serves as the Managing Director of Hansen & Rosenthal KG. Mr. Hansen has been Managing Director and served as Chairman of The Executive Board at H&R GmbH & Co. KGaA since January 01, 20...
CEO Compensation Analysis
Compensation vs Market: Niels's total compensation ($USD837.28K) is about average for companies of similar size in the German market ($USD973.43K).
Compensation vs Earnings: Niels's compensation has been consistent with company performance over the past year.
Board Members
Experienced Board: 2HRA's board of directors are considered experienced (9.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
H&R GmbH & Co. KGaA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: H&R GmbH & Co. KGaA
- Ticker: 2HRA
- Exchange: XTRA
- Founded: 1919
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: €288.841m
- Shares outstanding: 37.22m
- Website: https://www.hur.com
Number of Employees
Location
- H&R GmbH & Co. KGaA
- Neuenkirchener Strasse 8
- Salzbergen
- Lower Saxony
- 48499
- Germany
Listings
Biography
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and P...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/06/19 18:27 |
| End of Day Share Price | 2021/06/18 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.